I would like to think it would be a very positive sign. He would know better than most where IHL is with their research & an indication of the results from the research leading up to where we are now. We believe that IXHL is about to enter a much more liquid market with an audience far more interested/experienced in what we are offering. Joel has also mentioned they are pursuing a path to a GW pharma outcome. It makes a lot of sense to convert & adds another solid signal to the market we have an excellent chance of success with one or more of our development programs. IMOO
IHL Price at posting:
32.0¢ Sentiment: Buy Disclosure: Held